Integrating collection of biospecimens in clinical trials

The approach of the european organization for research and treatment of cancer

Jacqueline A. Hall, Maria Grazia Daidone, Godefridus J. Peters, Nadia Harbeck, Denis Lacombe, Stefan Sleijfer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Access to biospecimens and their derivatives, that is, human biological materials (HBM), for translational research (TR) is considered a major bottleneck hindering successful bench to bedside translation. Clinical trials offer a unique opportunity to collect HBM in a specialized setting that allows prospectively designed, high-quality TR that would be difficult to fulfill from community- or population-based HBM collections alone. Increasingly, as the field advances toward personalized treatment of cancer patients, access to HBM is becoming a necessity for patient enrollment in a new generation of clinical studies that are designed and driven by molecular hypotheses. The European Organization for Research and Treatment of Cancer (EORTC) is one of the largest networks for clinical trials in oncology. The EORTC is re-focusing its strategy, building on experiences and expertise gained over the years from specific initiatives such as EORTC Group activities and the EORTC Virtual Tumour Bank, by developing new mechanisms to support investigators with the practical aspects of HBM collection as part of EORTC clinical studies. Due to the complex, multidisciplinary nature of HBM collection and TR, integration of HBM collection into clinical trials warrants careful upfront planning and input from a range of expertise. To simplify HBM collection in clinical studies, the EORTC has developed a simple checklist containing the key elements of HBM collection setup and combines these into a simple tool for practical use. Through identifying and managing key risk areas, this can maximize the HBM collection success while achieving efficient clinical trial development. This article focuses on the key elements of HBM collection and the approaches of the EORTC for efficiently integrating this collection into clinical trial development.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalBiopreservation and Biobanking
Volume9
Issue number2
DOIs
Publication statusPublished - Jun 1 2011

Fingerprint

Biological materials
Clinical Trials
Organizations
Research
Neoplasms
Translational Medical Research
Therapeutics
Oncology
Checklist
Tumors
Research Personnel
Derivatives
Planning

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Cell Biology
  • Medicine (miscellaneous)

Cite this

Integrating collection of biospecimens in clinical trials : The approach of the european organization for research and treatment of cancer. / Hall, Jacqueline A.; Daidone, Maria Grazia; Peters, Godefridus J.; Harbeck, Nadia; Lacombe, Denis; Sleijfer, Stefan.

In: Biopreservation and Biobanking, Vol. 9, No. 2, 01.06.2011, p. 181-186.

Research output: Contribution to journalArticle

Hall, Jacqueline A. ; Daidone, Maria Grazia ; Peters, Godefridus J. ; Harbeck, Nadia ; Lacombe, Denis ; Sleijfer, Stefan. / Integrating collection of biospecimens in clinical trials : The approach of the european organization for research and treatment of cancer. In: Biopreservation and Biobanking. 2011 ; Vol. 9, No. 2. pp. 181-186.
@article{509973d3b47d4cbaa921de909d2e83f7,
title = "Integrating collection of biospecimens in clinical trials: The approach of the european organization for research and treatment of cancer",
abstract = "Access to biospecimens and their derivatives, that is, human biological materials (HBM), for translational research (TR) is considered a major bottleneck hindering successful bench to bedside translation. Clinical trials offer a unique opportunity to collect HBM in a specialized setting that allows prospectively designed, high-quality TR that would be difficult to fulfill from community- or population-based HBM collections alone. Increasingly, as the field advances toward personalized treatment of cancer patients, access to HBM is becoming a necessity for patient enrollment in a new generation of clinical studies that are designed and driven by molecular hypotheses. The European Organization for Research and Treatment of Cancer (EORTC) is one of the largest networks for clinical trials in oncology. The EORTC is re-focusing its strategy, building on experiences and expertise gained over the years from specific initiatives such as EORTC Group activities and the EORTC Virtual Tumour Bank, by developing new mechanisms to support investigators with the practical aspects of HBM collection as part of EORTC clinical studies. Due to the complex, multidisciplinary nature of HBM collection and TR, integration of HBM collection into clinical trials warrants careful upfront planning and input from a range of expertise. To simplify HBM collection in clinical studies, the EORTC has developed a simple checklist containing the key elements of HBM collection setup and combines these into a simple tool for practical use. Through identifying and managing key risk areas, this can maximize the HBM collection success while achieving efficient clinical trial development. This article focuses on the key elements of HBM collection and the approaches of the EORTC for efficiently integrating this collection into clinical trial development.",
author = "Hall, {Jacqueline A.} and Daidone, {Maria Grazia} and Peters, {Godefridus J.} and Nadia Harbeck and Denis Lacombe and Stefan Sleijfer",
year = "2011",
month = "6",
day = "1",
doi = "10.1089/bio.2011.0003",
language = "English",
volume = "9",
pages = "181--186",
journal = "Biopreservation and Biobanking",
issn = "1947-5535",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Integrating collection of biospecimens in clinical trials

T2 - The approach of the european organization for research and treatment of cancer

AU - Hall, Jacqueline A.

AU - Daidone, Maria Grazia

AU - Peters, Godefridus J.

AU - Harbeck, Nadia

AU - Lacombe, Denis

AU - Sleijfer, Stefan

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Access to biospecimens and their derivatives, that is, human biological materials (HBM), for translational research (TR) is considered a major bottleneck hindering successful bench to bedside translation. Clinical trials offer a unique opportunity to collect HBM in a specialized setting that allows prospectively designed, high-quality TR that would be difficult to fulfill from community- or population-based HBM collections alone. Increasingly, as the field advances toward personalized treatment of cancer patients, access to HBM is becoming a necessity for patient enrollment in a new generation of clinical studies that are designed and driven by molecular hypotheses. The European Organization for Research and Treatment of Cancer (EORTC) is one of the largest networks for clinical trials in oncology. The EORTC is re-focusing its strategy, building on experiences and expertise gained over the years from specific initiatives such as EORTC Group activities and the EORTC Virtual Tumour Bank, by developing new mechanisms to support investigators with the practical aspects of HBM collection as part of EORTC clinical studies. Due to the complex, multidisciplinary nature of HBM collection and TR, integration of HBM collection into clinical trials warrants careful upfront planning and input from a range of expertise. To simplify HBM collection in clinical studies, the EORTC has developed a simple checklist containing the key elements of HBM collection setup and combines these into a simple tool for practical use. Through identifying and managing key risk areas, this can maximize the HBM collection success while achieving efficient clinical trial development. This article focuses on the key elements of HBM collection and the approaches of the EORTC for efficiently integrating this collection into clinical trial development.

AB - Access to biospecimens and their derivatives, that is, human biological materials (HBM), for translational research (TR) is considered a major bottleneck hindering successful bench to bedside translation. Clinical trials offer a unique opportunity to collect HBM in a specialized setting that allows prospectively designed, high-quality TR that would be difficult to fulfill from community- or population-based HBM collections alone. Increasingly, as the field advances toward personalized treatment of cancer patients, access to HBM is becoming a necessity for patient enrollment in a new generation of clinical studies that are designed and driven by molecular hypotheses. The European Organization for Research and Treatment of Cancer (EORTC) is one of the largest networks for clinical trials in oncology. The EORTC is re-focusing its strategy, building on experiences and expertise gained over the years from specific initiatives such as EORTC Group activities and the EORTC Virtual Tumour Bank, by developing new mechanisms to support investigators with the practical aspects of HBM collection as part of EORTC clinical studies. Due to the complex, multidisciplinary nature of HBM collection and TR, integration of HBM collection into clinical trials warrants careful upfront planning and input from a range of expertise. To simplify HBM collection in clinical studies, the EORTC has developed a simple checklist containing the key elements of HBM collection setup and combines these into a simple tool for practical use. Through identifying and managing key risk areas, this can maximize the HBM collection success while achieving efficient clinical trial development. This article focuses on the key elements of HBM collection and the approaches of the EORTC for efficiently integrating this collection into clinical trial development.

UR - http://www.scopus.com/inward/record.url?scp=79959893005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959893005&partnerID=8YFLogxK

U2 - 10.1089/bio.2011.0003

DO - 10.1089/bio.2011.0003

M3 - Article

VL - 9

SP - 181

EP - 186

JO - Biopreservation and Biobanking

JF - Biopreservation and Biobanking

SN - 1947-5535

IS - 2

ER -